Adenosine Monophosphate* / analogs & derivatives

Oral COVID-19 Treatment VV116 Shows Promise with Minimal Impact from Liver Impairment A new oral antiviral, VV116 (too known as mindeudesivir), is demonstrating encouraging results in clinical trials for the …

Remdesivir for COVID-19: A Comprehensive Update Remdesivir, developed by Gilead Sciences, holds a significant place in the history of COVID-19 treatment. As the first drug to receive U.S. Food and …

Stability-Indicating HPLC Method for Remdesivir analysis in Pharmaceutical Formulations and Bioavailability Studies Table of Contents Stability-Indicating HPLC Method for Remdesivir analysis in Pharmaceutical Formulations and Bioavailability Studies Background on Remdesivir …

Understanding and Overcoming Resistance to Remdesivir in Coronavirus Treatment Primary Topic: Coronavirus antiviral resistance,specifically focusing on the mechanism of resistance to remdesivir and strategies to overcome it. Primary Keyword: Coronavirus …

Remdesivir Treatment and its association with Renal and Hepatic Function in Severe COVID-19 The clinical management of advanced COVID-19 often involves antiviral therapies like remdesivir. However, concerns persist regarding its …

Title: Unraveling the Link Between Parechovirus A3 and Fetal Thrombotic Vasculopathy: Insights and Implications Introduction: A New Discovery in Maternal and Fetal Health In a groundbreaking case study emerging from …

AI Innovations in Healthcare: A New Horizon for COVID-19 Treatment Strategies In the ever-evolving landscape of healthcare technology, artificial intelligence (AI) is forging new pathways to optimize treatment strategies for …